"GlycoVision results featured at ESMO 2024: read the interview here to learn how InterVenn is powering new prognostic and predictive biomarkers!
June 2, 2022
Glycoproteomics As A Powerful Liquid Biopsy-Based Predictor Of Checkpoint-Inhibitor Treatment Response

Get in touch